Fed will deliver another 25bp cut in December, Barclays says

Investing.com — Barclays anticipates that the Federal Reserve will implement another 25 basis point rate cut in December, according to insights from the minutes of the November 6-7 Federal Open Market Committee (FOMC) meeting. The bank said in a note Wednesday that the minutes reveal a Fed inclined toward gradual easing, contingent on labor market developments…

Read More

Futures dip as caution prevails ahead of inflation data

(Reuters) – U.S. stock index futures slipped on Wednesday as investors awaited key economic data, including a crucial inflation report, which is expected to influence the Federal Reserve’s future monetary policy path. The Personal Consumption Expenditure report, the central bank’s preferred inflation data, is due at 10 a.m. ET. Economists polled by Reuters expect prices…

Read More

Inflows into US equities surged post-election, Barclays says

Investing.com — Inflows into US equities surged to record levels following the US presidential election, according to a Barclays (LON:BARC) report. The post-election environment, shaped by renewed confidence in US exceptionalism, saw global equity flows hit $102 billion in November—the highest since March 2021. $109 billion flowed into US equities, a trend that helped fuel…

Read More

Johnson Matthey shares fall on weak H1 results

Investing.com — Shares of Johnson Matthey (LON:JMAT) were down 4.5% on Wednesday after the company reported weaker-than-expected results for the first half of fiscal 2025, with underlying EBIT falling short of both market expectations and year-ago levels.  The company’s underlying EBIT came in at £156 million, a 13% year-over-year decline and 13% below the Visible…

Read More

Grifols shares plunge after reports Brookfield considering dropping the takeover

Investing.com — Shares of Grifols (BME:GRLS) tanked over 13% on Wednesday after Brookfield, a Canadian investment firm, dropped its plan to buy Spain’s Grifols following disagreements over the pharmaceutical company’s valuation, Reuters reported on Wednesday Earlier this month, on November 19, Brookfield made a non-binding offer to purchase Grifols, valuing the human plasma-based drug developer…

Read More

Frontline shares dive 12% on profit slump

Investing.com — Frontline’s (OL:FRO) (NYSE:FRO) stock price took dropping over 12%, following its third-quarter 2024 financial results.  The company reported a year-over-year decrease in net profit for the quarter, with net income falling to $60.5 million, compared to $187.6 million in the same period of 2023.  This marks a near 70% drop in profitability, despite an…

Read More